Patient clusters based on HbA1c trajectories: A step toward individualized medicine in type 2 diabetes

Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease

(2017) Mei-Yueh Lee et al.   PLoS One

HbA1c and all-cause mortality risk among patients with type 2 diabetes

(2016) Weiqin Li et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2015) Silvio E. Inzucchi et al.   DIABETOLOGIA

Personalized Mortality Prediction Driven by Electronic Medical Data and a Patient Similarity Metric

(2015) Joon Lee et al.   PLoS One

NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set

(2015) Malika Charrad et al.   Journal of Statistical Software

Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

(2014) Evangelos Kontopantelis et al.   DIABETOLOGIA

Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes

(2014) Ramit Ravona-Springer et al.   PLoS One

Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

(2013) Faramarz Ismail-Beigi et al.   ANNALS OF INTERNAL MEDICINE

Variability in hemoglobin A1c predicts all-cause mortality in patients with type 2 diabetes

(2012) Wen-Ya Ma et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease

(2011) Sabin Shurraw   ARCHIVES OF INTERNAL MEDICINE

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE